Literature DB >> 11159978

Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F.

A H Lucas1, K D Moulton, V R Tang, D C Reason.   

Abstract

Antibodies specific for capsular polysaccharides play a central role in immunity to encapsulated Streptococcus pneumoniae, but little is known about their genetics or the variable (V) region polymorphisms that affect their protective function. To begin to address these issues, we used combinatorial library cloning to isolate pneumococcal polysaccharide (PPS)-specific Fab fragments from two vaccinated adults. We determined complete V region primary structures and performed antigen binding analyses of seven Fab fragments specific for PPS serotype 6B, 14, or 23F. Fabs were of the immunoglobulin G2 or A isotype. Several V(H)III gene segments (HV 3-7, 3-15, 3-23, and 3-11) were identified. V(L) regions were encoded by several kappa genes (KV 4-1, 3-15, 2-24, and 2D-29) and a lambda gene (LV 1-51). Deviation of the V(H) and V(L) regions from their assigned germ line counterparts indicated that they were somatically mutated. Fabs of the same serotype specificity isolated from a single individual differed in affinity, and these differences could be accounted for either by the extent of mutation among clonal relatives or by usage of different V-region genes. Thus, functionally disparate anti-PPS antibodies can arise within individuals both by activation of independent clones and by intraclonal somatic mutation. For one pair of clonally related Fabs, the more extensively mutated V(H) was associated with lower affinity for PPS 14, a result suggesting that somatic mutation could lead to diminished protective efficacy. These findings indicate that the PPS repertoire in the adult derives from memory B-cell populations that have class switched and undergone extensive hypermutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159978      PMCID: PMC97962          DOI: 10.1128/IAI.69.2.853-864.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Somatic insertions and deletions shape the human antibody repertoire.

Authors:  R M de Wildt; W J van Venrooij; G Winter; R M Hoet; I M Tomlinson
Journal:  J Mol Biol       Date:  1999-12-03       Impact factor: 5.469

2.  The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B.

Authors:  M K Park; Y Sun; J V Olander; J W Hoffmann; M H Nahm
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III. A single VKII gene and one of several JK genes are joined by an invariant arginine to form the most common L chain V region.

Authors:  M G Scott; D L Crimmins; D W McCourt; I Zocher; R Thiebe; H G Zachau; M H Nahm
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

4.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families.

Authors:  M G Scott; J J Tarrand; D L Crimmins; D W McCourt; N R Siegel; C E Smith; M H Nahm
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

5.  Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.

Authors:  C Lue; A Tarkowski; J Mestecky
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

Review 6.  Polysaccharide vaccines as probes of antibody repertoires in man.

Authors:  A H Lucas; D C Reason
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

7.  The progeny of a single virgin B cell predominates the human recall B cell response to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  T Barington; L Hougs; L Juul; H O Madsen; L P Ryder; C Heilmann; A Svejgaard
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 8.  Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Authors:  J B Robbins; R Austrian; C J Lee; S C Rastogi; G Schiffman; J Henrichsen; P H Mäkelä; C V Broome; R R Facklam; R H Tiesjema
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

9.  Immunogenetic analysis of the immune response to pneumococcal polysaccharide.

Authors:  H E Baxendale; Z Davis; H N White; M B Spellerberg; F K Stevenson; D Goldblatt
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

10.  A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons.

Authors:  Q Chang; J Abadi; P Alpert; L Pirofski
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

View more
  27 in total

1.  Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F.

Authors:  Jianhui Zhou; Kathleen R Lottenbach; Stephen J Barenkamp; Alexander H Lucas; Donald C Reason
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Phenotypic analysis of pneumococcal polysaccharide-specific B cells.

Authors:  Noor Khaskhely; Jason Mosakowski; Rebecca S Thompson; Sadik Khuder; S Louise Smithson; M A Julie Westerink
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

3.  A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors:  Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells.

Authors:  David J Leggat; Rebecca S Thompson; Noor M Khaskhely; Anita S Iyer; M A Julie Westerink
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

5.  Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice.

Authors:  Jesus Colino; Clifford M Snapper
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

6.  Differential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccine.

Authors:  Jesus Colino; Leah Duke; Swadhinya Arjunaraja; Quanyi Chen; Leyu Liu; Alexander H Lucas; Clifford M Snapper
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

7.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

8.  IGH V3-23*01 and its allele V3-23*03 differ in their capacity to form the canonical human antibody combining site specific for the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  Leyu Liu; Alexander H Lucas
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

9.  The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen.

Authors:  Taia T Wang; Alexander H Lucas
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

Authors:  Sandra Weller; Moritz C Braun; Bruce K Tan; Andreas Rosenwald; Corinne Cordier; Mary Ellen Conley; Alessandro Plebani; Dinakhanta S Kumararatne; Damien Bonnet; Olivier Tournilhac; Gil Tchernia; Birte Steiniger; Louis M Staudt; Jean-Laurent Casanova; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.